Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $823.0K | $4.5M | $5.5M | $26.0M | $7.1M |
| Cost of revenue | $0 | $0 | $8.3M | $14.4M | $20.0M | $35.0M | $0 | $0 |
| Gross profit | $0 | $0 | −$8.3M | −$13.6M | −$15.5M | −$29.5M | $0 | $0 |
| Gross margin | — | — | — | -1655.0% | -347.4% | -535.7% | 0.0% | 0.0% |
| R&D | $12.7M | $15.1M | $9.8M | $14.4M | $20.0M | $35.0M | $51.0M | $91.0M |
| Operating income | −$15.5M | −$10.9M | −$18.0M | −$21.6M | −$23.8M | −$36.9M | −$67.5M | −$114.4M |
| EBITDA | −$13.9M | −$9.5M | −$16.6M | −$20.5M | −$22.7M | −$36.1M | −$67.5M | −$114.4M |
| Net income | −$15.1M | −$16.7M | −$19.5M | −$22.2M | −$23.2M | −$36.9M | −$63.7M | −$20.6M |
| Net margin | — | — | — | -2695.1% | -517.5% | -670.2% | -245.1% | -288.3% |
| EPS (diluted) | -2.25 | -3.59 | -2.43 | -1.35 | -0.96 | -1.08 | -2.36 | -0.33 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ARPO.
No tracked institution reports a position in ARPO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-08-27 | 1-for-15reverse |
No one on the platform has traded ARPO yet.
| $47M |
| — |
| HTBXHeat Biologics, Inc. | $2.38 | +0.42% | $61M | — |
| KRONKronos Bio, Inc. | $0.88 | +1.49% | $54M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.